Rossdorf, Germany

Eckhard Oelrich

This inventor holds 2 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gmbh. Active years: 1988-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1988-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eckhard Oelrich: Innovator in Pharmaceutical Compositions

Introduction

Eckhard Oelrich is a notable inventor based in Rossdorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. With a total of 2 patents, Oelrich's work has had a meaningful impact on medical formulations.

Latest Patents

Oelrich's latest patents include a composition for cefixime, which is characterized by its syrup-like characteristics and the absence of thickening ancillary substances. This invention features a microfine powder of bulking agent, ensuring that the composition is easily redispersible and chemically stable. Another significant patent involves a solution of luprostiol and 1,2-propanediol, which is formulated to maintain a specific pH and includes luprostiol in the form of its sodium salt.

Career Highlights

Throughout his career, Eckhard Oelrich has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise in patentable innovations.

Collaborations

Oelrich has collaborated with notable colleagues such as Joachim Bolz and Gertraud Wagner, contributing to the advancement of pharmaceutical research and development.

Conclusion

Eckhard Oelrich's contributions to pharmaceutical compositions demonstrate his innovative spirit and commitment to improving medical formulations. His patents reflect a deep understanding of the complexities involved in drug development, making him a valuable figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…